Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Yongde Luo"'
Autor:
Zhifeng Huang, Tongtong Pan, Liang Xu, Lu Shi, Xiong Ma, Liya Zhou, Luyao Wang, Jiaojiao Wang, Guoqing Zhu, Dazhi Chen, Lingtao Song, Xiaomin Pan, Xiaodong Wang, Xiaokun Li, Yongde Luo, Yongping Chen
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 14, Iss 6, Pp 2791-2793 (2024)
Externí odkaz:
https://doaj.org/article/e8efc81265814d7c874f989b0517eca9
Autor:
Zhifeng Huang, Tongtong Pan, Liang Xu, Lu Shi, Xiong Ma, Liya Zhou, Luyao Wang, Jiaojiao Wang, Guoqing Zhu, Dazhi Chen, Lingtao Song, Xiaomin Pan, Xiaodong Wang, Xiaokun Li, Yongde Luo, Yongping Chen
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 14, Iss 4, Pp 1605-1623 (2024)
Immune-mediated liver injury (ILI) is a condition where an aberrant immune response due to various triggers causes the destruction of hepatocytes. Fibroblast growth factor 4 (FGF4) was recently identified as a hepatoprotective cytokine; however, its
Externí odkaz:
https://doaj.org/article/5756349c51df4eb880a69f903e1fcdd2
Autor:
Weiqin Lu, Yongde Luo
Publikováno v:
Cancer Communications, Vol 43, Iss 11, Pp 1267-1270 (2023)
Externí odkaz:
https://doaj.org/article/d281d138b17d4f68bbd257d9ba7350f1
Autor:
Feng Qi, Wenxing Qin, Yao Zhang, Yongde Luo, Bing Niu, Quanlin An, Biwei Yang, Keqing Shi, Zhijie Yu, Junwei Chen, Xin Cao, Jinglin Xia
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-19 (2021)
Abstract Background Recurrent hepatocellular carcinoma (HCC) shows strong resistance to sorafenib, and the tumor-repopulating cells (TRCs) with cancer stem cell-like properties are considered a driver for its high recurrent rate and drug resistance.
Externí odkaz:
https://doaj.org/article/b3a503565fdd489584f52d12cff78b3c
Autor:
Muyun Liu, Dan Wang, Yongde Luo, Lianghao Hu, Yawei Bi, Juntao Ji, Haojie Huang, Guoqiang Wang, Liang Zhu, Jianjia Ma, Eunice Kim, Catherine K. Luo, James L. Abbruzzese, Xiaokun Li, Vincent W. Yang, Zhaoshen Li, Weiqin Lu
Publikováno v:
Cell Death and Disease, Vol 12, Iss 2, Pp 1-15 (2021)
Abstract Oncogenic RAS is a critical driver for the initiation and progression of several types of cancers. However, effective therapeutic strategies by targeting RAS, in particular RASG12D and RASG12V, and associated downstream pathways have been so
Externí odkaz:
https://doaj.org/article/45fa13ee9d154ce6ab7368e68890eaef
Autor:
Dan Wang, Yawei Bi, Lianghao Hu, Yongde Luo, Juntao Ji, Albert Z. Mao, Craig D. Logsdon, Ellen Li, James L. Abbruzzese, Zhaoshen Li, Vincent W. Yang, Weiqin Lu
Publikováno v:
Cell Communication and Signaling, Vol 17, Iss 1, Pp 1-9 (2019)
Abstract Oncogenic KRAS plays a vital role in controlling tumor metabolism by enhancing aerobic glycolysis. Obesity driven by chronic consumption of high-fat diet (HFD) is a major risk factor for oncogenic KRAS-mediated pancreatic ductal adenocarcino
Externí odkaz:
https://doaj.org/article/ae0f83ad196b454d86c5e4a13795292a
Autor:
Anmin Huang, Feixia Guo, Zhijie Yu, Pixu Liu, Shiying Dong, Yunjie Zhang, Yifan Kong, Xiuyan Kong, Ting Li, Yongde Luo, Hongping Xia, Keqing Shi, Jinglin Xia
Publikováno v:
ACS Applied Materials & Interfaces. 15:10371-10382
Publikováno v:
Journal of Renewable Materials. :1-11
Autor:
Chengshui Chen, Feng Qi, Keqing Shi, Yuping Li, Ji Li, Yongping Chen, Jingye Pan, Tieli Zhou, Xiangyang Lin, Jinsan Zhang, Yongde Luo, Xiaokun Li, Jinglin Xia
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 2, Pp n/a-n/a (2020)
Externí odkaz:
https://doaj.org/article/a1cda4824aa548b0ae0bbc1ffc4022a2
Publikováno v:
Materials Research Express, Vol 9, Iss 5, p 055503 (2022)
The catalyst particles were removed from fluid catalytic cracking (FCC) slurry oil by two-step separation processing. FCC slurry oil was mixed with water and surfactant to make the lower viscosity emulsion. The catalyst particles were removed from th
Externí odkaz:
https://doaj.org/article/2308f49626be482f91d19d86b168fbaf